Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115563) titled 'Efficacy and Safety of Methylene Blue in Severe Septic Shock: A Prospective Randomized Controlled Trial' on Dec. 29, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ningbo Beilun People's Hospital
Condition:
Septic Shock
Intervention:
Methylene blue intervention group:Use methylene blue
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-01-01
Target Sample Size: Methylene blue intervention group:244;Saline placebo group:244;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=302580
Disclaimer: Cu...